Next Stage One: Navigating Licensing and Investor Alignment to Drive Commercialisation

For emerging biotech companies, the right partnerships are pivotal to growth. Dr. Tony Sasse, Founder & Managing Director of Snoretox, shares how his team identified investors and collaborators who believed in their mission and understood their market. Learn how strategic alignment is helping Snoretox progress toward licensing and manufacturing deals that will bring their innovation to market.